Wednesday, December 4 | 2:00 p.m.-2:10 p.m. | W6-SSOB03-4 | E351
In this session, audience members will learn about the role of transvaginal ultrasound (TVUS) in detecting endometriosis early in women.
Martina Francisco, MD, from Stanford University, will present the study's findings, which showed that nearly three in 10 women undergoing routine TVUS for any cause had equivocal or positive ultrasound findings of endometriosis.
The Society of Radiologists in Ultrasound (SRU) in 2024 provided a consensus statement on routine pelvic ultrasound for endometriosis. This established the clinical criteria for performing an augmented pelvic ultrasound.
In their study, the researchers analyzed a retrospective cohort of women who underwent routine TVUS to identify findings suggestive of endometriosis. They implemented the following SRU consensus classifications for interpreting ultrasound: normal (APU-1), equivocal for endometriosis (APU-2), and positive for endometriosis (APU-3). Two readers with five and 10 years of experience evaluated the imaging findings in consensus.
The final analysis included 76 consecutive female patients with an average age of 44.6 years. Of these, 24 would have met the clinical criteria for augmented ultrasound. Another five women had imaging findings equivocal for endometriosis on routine TVUS, three of which were found to not have prior history of the disease.
Also, 16 women had imaging findings that were deemed positive for endometriosis. Of these, 11 did not yet have an established diagnosis during follow-up.
Finally, among the 21 women with equivocal or positive findings on routine TVUS, 11 met clinical criteria for having augmented ultrasound performed. And of the 24 women who met clinical criteria for augmented ultrasound, eight were classified as positive for endometriosis.
Attend this session to find out how these results can better inform screening and treatment strategies.
